Big Pharma’s Busiest Deal-Makers In 2021 Were Less Prolific Than In 2020

 
• By Joseph Haas
  
Back view image of young businessman standing against business sketch
2021 was a busy deal-making year in big pharma, with M&A up slightly and alliances down a bit • Source: Shutterstock
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from Growth

More from In Vivo